Template CTD Dossier (without supply)

rss
 
noimage.gif
1. An entirely new combination. An original analgesic, which is not a scheduled drug. 2. The combination is in complete compliance with a global trend of multimodal analgesia.  3.  The option for adequate pain control (equivalent to morphine) achieved with low doses and with minimal complications and adverse effects.   The conditions for licensing-out selling of the product. 1. Documents to be transferred:   -     Pharmaceutical...
noimage.gif
Farmavita.Net members, from India,  are offering  license-out  of formulation documentation for more than two hundred (200)  pharmaceutical products. Each CTDossier is available for lump sum payment, without supply obligation. This Dossiers does not include  clincal studies.   Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product.  It is expected that buyer of...

Advert search

Recent adverts

A pharmaceutical company from Turkey, selling...
43 Views
Wuxi Griffin Pharmaceuticals Co. Ltd. is...
107 Views
A pharmaceutical company from Turkey, selling...
111 Views
Active substance formulated into Tivortin®  –...
149 Views
1. An entirely new combination. An original...
126 Views
I’m a representative of Parafarm (Penza,...
981 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
850 Views